SWM
GILD icon

Sanctuary Wealth Management’s Gilead Sciences GILD Stock Holding History

Sanctuary Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$36K Hold
390
– – 0.02% 106
2024
Q3 		$32.7K Hold
390
– – 0.02% 120
2024
Q2 		$26.8K Hold
390
– – 0.02% 114
2024
Q1 		$28.6K Hold
390
– – 0.02% 112
2023
Q4 		$31.6K Hold
390
– – 0.03% 101
2023
Q3 		$29.2K Hold
390
– – 0.03% 92
2023
Q2 		$30.1K Buy
+390
New +$31.1K 0.03% 94
2022
Q4 		$33.5K Buy
+390
New +$30.9K 0.04% 83

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanctuary Wealth Management's GILD Position: Q4 2024 in Review

Sanctuary Wealth Management held its Gilead Sciences (GILD) position steady in Q4 2024 at 390 shares worth $36K. The position accounts for 0.02% of the portfolio, ranked #106.

Sanctuary Wealth Management first reported a position in GILD in Q4 2022 and has held it in 8 quarters since. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Sanctuary Wealth Management held 390 shares of Gilead Sciences worth $36K as of Q4 2024.
  • Sanctuary Wealth Management left its Gilead Sciences share count unchanged in Q4 2024.
  • Gilead Sciences made up 0.02% of Sanctuary Wealth Management's portfolio in Q4 2024, its #106 holding.
  • Sanctuary Wealth Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 8 quarters since.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Sanctuary Wealth Management's 13F filing for Q4 2024, filed 12 Feb 2025.